Purchases and Sales Made in Q4 2021 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q4 2021. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2022
Q4 2021
|
Empowered Funds, LLC
|
SELL
|
- |
-34.8KClosed |
$1.24M - $1.96M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-35.6K- 6.46% |
$1.27M - $2M
|
515K
$12.3M
|
|
|
Feb 09, 2022
Q4 2021
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-35.8K- 38.35% |
$1.28M - $2.02M
|
57.6K
$1.37M
|
|
|
Feb 14, 2022
Q4 2021
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-43.2K- 75.98% |
$1.54M - $2.43M
|
13.6K
$324K
|
|
|
Feb 14, 2022
Q4 2021
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-44.4KClosed |
$1.58M - $2.5M
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
- |
-46.5K- 63.7% |
$1.66M - $2.62M
|
26.5K
$630K
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-53.5K- 17.38% |
$1.91M - $3.01M
|
254K
$6.05M
|
|
|
Feb 14, 2022
Q4 2021
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-59K- 31.89% |
$2.11M - $3.32M
|
126K
$3M
|
|
|
Feb 14, 2022
Q4 2021
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-69.5K- 45.12% |
$2.48M - $3.91M
|
84.5K
$2.01M
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-83.6K- 39.54% |
$2.98M - $4.71M
|
128K
$3.04M
|
|
|
Feb 11, 2022
Q4 2021
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-86.4KClosed |
$3.08M - $4.86M
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Eam Global Investors LLC
Solana Beach, CA |
SELL
|
- |
-96.5KClosed |
$3.44M - $5.43M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-141K- 14.31% |
$5.03M - $7.93M
|
844K
$20.1M
|
|
|
Feb 11, 2022
Q4 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-161KClosed |
$5.75M - $9.08M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-164K- 41.62% |
$5.84M - $9.22M
|
230K
$5.46M
|
|
|
Feb 14, 2022
Q4 2021
|
Cowen And Company, LLC
|
SELL
|
- |
-183K- 28.14% |
$6.52M - $10.3M
|
467K
$11.1M
|
|
|
Nov 08, 2023
Q4 2021
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-193K- 24.6% |
$6.9M - $10.9M
|
592K
$14.1M
|
|
|
Feb 14, 2022
Q4 2021
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-233K- 21.22% |
$8.32M - $13.1M
|
865K
$20.6M
|
|
|
Feb 14, 2022
Q4 2021
|
Commodore Capital LP
New York, NY |
SELL
|
- |
-248KClosed |
$8.86M - $14M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-300K- 31.58% |
$10.7M - $16.9M
|
650K
$15.5M
|
|
|
Feb 14, 2022
Q4 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-326K- 61.11% |
$11.6M - $18.4M
|
208K
$4.94M
|
|
|
Feb 14, 2022
Q4 2021
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-878K- 28.84% |
$31.3M - $49.4M
|
2.17M
$51.5M
|